Vitaccess real-world evidence

We offer invaluable insights across the product life cycle


Vitaccess real-world evidence

We offer invaluable insights across the product life cycle


Our patient-centric real-world evidence studies powered by the Vitaccess Real™ platform enable you to obtain deeper, faster insights into the impact of diseases and treatment in the real world.

RWE studies provide valuable data for a multitude of uses across the product life cycle, including:

  • Characterizing the impact of diseases and treatments on patients and caregivers

  • Informing portfolio decisions and product positioning

  • Delivering rich publication opportunities

  • Improving clinical trial designs

  • Supporting regulatory and health technology assessment submissions

  • Fulfilling post-marketing evidence-generation commitments

To date, our studies have covered therapeutic areas such as oncology, rare diseases, and allergies:

  • Melanoma

  • Beta-thalassemia (TDT)

  • Charcot-Marie-Tooth disease (CMT)

  • Myasthenia gravis (MG)

  • Cystic fibrosis (CF)

  • Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)

  • Monocarboxylate transporter 8 deficiency (MCT8 deficiency)

  • Peanut allergy

The Vitaccess approach

Full Service Offering

In-house design and implementation combining multidisciplinary expertise with our next-generation Vitaccess Real™ platform


Thousands of patient and caregiver participants already recruited across many indications


Rigorously localized studies in North America, Europe and Asia


Customizable modular platform enabling tailored study design


Gold-standard data security, GDPR and HIPAA compliant, ISO 9001, 27001 and 17100 certified




Multi-stakeholder co-creation with patient groups and clinical experts, enabling an inclusive methodology and patient-relevant data collection

A next-gen real-world evidence platform
connecting biopharma to patients
on any device, worldwide

Remote data capture

Real-time analysis

Patient and caregiver data
to optimize your submissions

real-world evidence platform

Real data. Patient progress.

Skip to content